Validant Acquires Clinical Outcomes Solutions, a Global Leader in COA Research

Validant, a leading global quality, compliance and regulatory consulting group, has acquired Clinical Outcomes Solutions (COS), a global leader in clinical outcomes assessments (COA). 

COS was founded in 2013 and has developed a leadership position in COA through its patient-centered approach and by building the deepest and broadest set of quantitative, scientific and analytical capabilities in the market. COA is a fast-growing niche of the health economics and outcomes research (HEOR) market focused on the patient experience. 

Validant’s acquisition of COS, headquartered in the UK, is another important step in its international growth strategy, focused on combining best-in-class regulatory driven life science consultancies, and continuing their growth with further investment.

This announcement follows Validant’s acquisition of:

  • Greenleaf Health, a leading U.S. Food and Drug Administration (FDA) regulatory consulting firm in April 2021
  • Oriel STAT A MATRIX, a New Jersey-based global consultancy and training firm in December 2020
  • IDEC, a leading regulatory consultancy in Japan in November 2020
  • DataRevive, a regulatory strategy and consultancy for global clients, based in Washington D.C. in 2019

Commenting on the announcement, Patrick Ronan, CEO of Validant, said: "We are once again delighted to welcome another best-in-class provider into the Validant family, further expanding the Group’s service offering into HEOR and COA. Clinical Outcomes Solutions is a true category leader supporting customers across all facets of clinical outcomes research to improve patient care. We look forward to working together to better serve our combined customers."

Stacie Hudgens, CEO of COS said: “The team and I have spent the last eight years developing innovative scientific methods to capture and communicate the patient voice. In Validant, we have found a company that shares our patient-centered beliefs, and we look forward to working together to grow our business, helping clients and patients around the world.”

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox!
Sign up now!

  • <<
  • >>

Join the Discussion